Vanda Pharmaceuticals (VNDA) Adopts Limited Duration Stockholder Rights Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to Vanda Pharmaceuticals (VNDA) Adopts Limited Duration Stockholder Rights Plan
April 17, 2024 10:21 AM EDT
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.
... More
April 17, 2024 9:02 AM EDT
Board Determined Unsolicited Takeover Proposals Significantly Undervalue the Company
No Shareholder Action Required at This Time
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that, since March 2024, it received several unsolicited proposals from Future Pak, LLC ("Future Pak"), to acquire all of the outstanding shares of Vanda (the "Conditional Proposals"). The most recent... More
April 17, 2024 6:30 AM EDT
Future Pak proposes to acquire 100% of the issued and outstanding shares of Vanda
Implies a premium of 79.0% to 91.4% to Vanda's closing price of $4.05 as of April 16, 2024
Proposal is based on public information, and Future Pak is open to increasing the value of its offer based on due diligence and good faith negotiations with Vanda and its Board
WIXOM, Mich.--(BUSINESS WIRE)--
Future Pak LLC (Future Pak) today announced that it has submitted three proposals since February to acquire all of the outstanding... More
